Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to show superiority of Rotigotine over placebo on improvement
of depressive symptoms in subjects with idiopathic Parkinson's disease.